BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

818 related articles for article (PubMed ID: 32841663)

  • 1. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
    Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
    Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-573 inhibits cell proliferation, migration and invasion and is downregulated by PICSAR in cutaneous squamous cell carcinoma.
    Wang Y; Tang S; Lv J
    Bosn J Basic Med Sci; 2022 Apr; 22(2):229-237. PubMed ID: 34905724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USF1-induced upregulation of LINC01048 promotes cell proliferation and apoptosis in cutaneous squamous cell carcinoma by binding to TAF15 to transcriptionally activate YAP1.
    Chen L; Chen Q; Kuang S; Zhao C; Yang L; Zhang Y; Zhu H; Yang R
    Cell Death Dis; 2019 Apr; 10(4):296. PubMed ID: 30931936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H3K27 acetylation-induced lncRNA EIF3J-AS1 improved proliferation and impeded apoptosis of colorectal cancer through miR-3163/YAP1 axis.
    Liu D; Zhang H; Cong J; Cui M; Ma M; Zhang F; Sun H; Chen C
    J Cell Biochem; 2020 Feb; 121(2):1923-1933. PubMed ID: 31709617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0023028 contributes to the progression of laryngeal squamous cell carcinoma by upregulating LASP1 through miR-486-3p.
    Zheng Y; Duan L; Yang Y; Luo D; Yan B
    Mol Cell Biochem; 2021 Aug; 476(8):2951-2961. PubMed ID: 33755879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR-363-3p.
    Rong H; Chen B; Wei X; Peng J; Ma K; Duan S; He J
    Thorac Cancer; 2020 Mar; 11(3):659-671. PubMed ID: 31968395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA SCARNA2 induces cutaneous squamous cell carcinoma progression via modulating miR-342-3p expression.
    Zhang Z; Jia M; Wen C; He A; Ma Z
    J Gene Med; 2020 Dec; 22(12):e3242. PubMed ID: 32558970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA RP11-757G1.5 sponges miR-139-5p and upregulates YAP1 thereby promoting the proliferation and liver, spleen metastasis of colorectal cancer.
    Zhu X; Bu F; Tan T; Luo Q; Zhu J; Lin K; Huang J; Luo C; Zhu Z
    J Exp Clin Cancer Res; 2020 Oct; 39(1):207. PubMed ID: 33023613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion.
    Xu N; Zhang L; Meisgen F; Harada M; Heilborn J; Homey B; Grandér D; Ståhle M; Sonkoly E; Pivarcsi A
    J Biol Chem; 2012 Aug; 287(35):29899-908. PubMed ID: 22782903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA LINC00152 Increases the Aggressiveness of Human Retinoblastoma and Enhances Carboplatin and Adriamycin Resistance by Regulating MiR-613/Yes-Associated Protein 1 (YAP1) Axis.
    Wang Y; Xin D; Zhou L
    Med Sci Monit; 2020 Jun; 26():e920886. PubMed ID: 32541644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lnc-PICSAR contributes to cisplatin resistance by miR-485-5p/REV3L axis in cutaneous squamous cell carcinoma.
    Wang D; Zhou X; Yin J; Zhou Y
    Open Life Sci; 2020; 15(1):488-500. PubMed ID: 33817237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Noncoding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity.
    Piipponen M; Nissinen L; Farshchian M; Riihilä P; Kivisaari A; Kallajoki M; Peltonen J; Peltonen S; Kähäri VM
    J Invest Dermatol; 2016 Aug; 136(8):1701-1710. PubMed ID: 27049681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircRNA circ_0067772 aggravates the malignant progression of cutaneous squamous cell carcinoma by regulating miR-1238-3p/FOXG1 axis.
    Li X; Kong Y; Li H; Xu M; Jiang M; Sun W; Xu S
    Genes Genomics; 2021 May; 43(5):491-501. PubMed ID: 33709381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-125b exerts antitumor functions in cutaneous squamous cell carcinoma by targeting the STAT3 pathway.
    Tian K; Liu W; Zhang J; Fan X; Liu J; Zhao N; Yao C; Miao G
    Cell Mol Biol Lett; 2020; 25():12. PubMed ID: 32161621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
    Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
    J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA circFADS2 inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-766-3p/HOXA9 axis.
    Zhang Z; Sun H; Hou J; Li L; Wu L
    Histol Histopathol; 2022 Apr; 37(4):335-348. PubMed ID: 34913472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The knockdown of SNHG3 inhibits the progression of laryngeal squamous cell carcinoma by miR-340-5p/YAP1 axis and Wnt/β-catenin pathway.
    Kang R; Yao DF; Xu GZ; Zhou YH
    Neoplasma; 2020 Sep; 67(5):1094-1105. PubMed ID: 32538668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The knockdown of LncRNA AFAP1-AS1 suppressed cell proliferation, migration, and invasion, and promoted apoptosis by regulating miR-545-3p/hepatoma-derived growth factor axis in lung cancer.
    Sun J; Min H; Yu L; Yu G; Shi Y; Sun J
    Anticancer Drugs; 2021 Jan; 32(1):11-21. PubMed ID: 33290312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA circ-LARP1B contributes to cutaneous squamous cell carcinoma progression by targeting microRNA-515-5p/TPX2 microtubule nucleation factor axis.
    Wang L; Hou S; Li J; Tian T; Hu R; Yu N
    Bioengineered; 2022 Jan; 13(1):1209-1223. PubMed ID: 34982022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.